Marija Maskalan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marija Maskalan has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Zorana Grubic
Tissue Typing Centre, Clinical Department for Transfusion Medicine and Transplantation Biology University Hospital Centre Zagreb Zagreb Croatia
6 shared publications - Katarina Stingl Jankovic
Tissue Typing Centre, Clinical Department for Transfusion Medicine and Transplantation Biology University Hospital Centre Zagreb Zagreb Croatia
4 shared publications - Marija Burek Kamenaric
Tissue Typing Centre, Clinical Department for Transfusion Medicine and Transplantation Biology University Hospital Centre Zagreb Zagreb Croatia
4 shared publications - Renata Zunec
Tissue Typing Centre, Clinical Department for Transfusion Medicine and Transplantation Biology, University Hospital Centre Zagreb, Zagreb, Croatia
3 shared publications Katarina Stingl Jankovic
Tissue Typing Centre, Clinical Department for Transfusion Medicine and Transplantation Biology University Hospital Centre Zagreb Zagreb Croatia
2 shared publicationsR. Zunec
Tissue Typing Centre, Department of Transfusion Medicine and Transplantation Biology Clinical Hospital Centre Zagreb Zagreb Croatia
2 shared publications
Latest Publications
Diversity of the HLA 8.1 Extended Haplotype in the Croatian Population and Identification of a Novel Allele HLA‐DRB3*01:132N
The HLA 8.1 extended haplotype is a well‐defined haplotype within the HLA region, characterised by strong linkage disequilibrium (LD) and recognised as most prevalent among populations of European ancestry. Despite its significance, comprehensive data on the extended 8.1 haplotype, encompassing all nine HLA loci with high‐resolution typing, remains limited. In this study we examined the structure of the 8.1 haplotype in a cohort of 146 unrelated Croatian individuals ( HLA‐A*01 ; C*07 ; B*08 ; DRB1*03 homozygous at low resolution level), who were additionally NGS typed for HLA‐A, ‐C, ‐B, ‐DRB1, ‐DRB3/4/5, ‐DQA1, ‐DQB1, ‐DPA1 and ‐DPB1 loci. All individuals remained homozygous at the HLA‐DRB1 locus (100%) with only a single allele observed, while the HLA‐DPB1 locus showed the lowest homozygosity (31.5%), with 18 distinct alleles identified. Four novel alleles were detected in this cohort, of which the HLA‐DRB3*01:132N allele is reported here for the first time. The analysis of 4th field allelic differences revealed 30 distinct haplotypes, with HLA‐A*01:01:01:01 ~ C*07:01:01:01 ~ B*08:01:01:01 ~ DRB1*03:01:01:01 ~ DRB3*01:01:02:01 ~ DQA1*05:01:01:02 ~ DQB1*02:01:01:01 ~ DPA1*02:01:02:02 ~ DPB1*01:01:01:01 being the most frequent one (47.9%). Out of 146 individuals, 43 (29.5%) were homozygous for all nine HLA loci, encompassing three distinct haplotypes. In addition, the two (out of 21 different combinations) most frequent HLA‐DPA1~DPB1 haplotypes were HLA‐DPA1*02:01:02:02 ~ DPB1*01:01:01:01 and HLA‐DPA1*01:03:01:02 ~ DPB1*04:01:01:01 which were significantly more prevalent ( P corr < 0.0001 each). Our study provides valuable insights on the polymorphism of nine HLA loci within 8.1 extended haplotype, highlighting 4th‐field allelic variations and potential haplotype formation preferences. Additionally, it underscores the genetic diversity of HLA‐DPA1~DPB1 within 8.1 extended haplotype, which may influence its role in disease associations.
Diversity of the HLA 8.1 Extended Haplotype in the Croatian Population and Identification of a Novel Allele HLA‐DRB3*01:132N
The HLA 8.1 extended haplotype is a well‐defined haplotype within the HLA region, characterised by strong linkage disequilibrium (LD) and recognised as most prevalent among populations of European ancestry. Despite its significance, comprehensive data on the extended 8.1 haplotype, encompassing all nine HLA loci with high‐resolution typing, remains limited. In this study we examined the structure of the 8.1 haplotype in a cohort of 146 unrelated Croatian individuals ( HLA‐A*01 ; C*07 ; B*08 ; DRB1*03 homozygous at low resolution level), who were additionally NGS typed for HLA‐A, ‐C, ‐B, ‐DRB1, ‐DRB3/4/5, ‐DQA1, ‐DQB1, ‐DPA1 and ‐DPB1 loci. All individuals remained homozygous at the HLA‐DRB1 locus (100%) with only a single allele observed, while the HLA‐DPB1 locus showed the lowest homozygosity (31.5%), with 18 distinct alleles identified. Four novel alleles were detected in this cohort, of which the HLA‐DRB3*01:132N allele is reported here for the first time. The analysis of 4th field allelic differences revealed 30 distinct haplotypes, with HLA‐A*01:01:01:01 ~ C*07:01:01:01 ~ B*08:01:01:01 ~ DRB1*03:01:01:01 ~ DRB3*01:01:02:01 ~ DQA1*05:01:01:02 ~ DQB1*02:01:01:01 ~ DPA1*02:01:02:02 ~ DPB1*01:01:01:01 being the most frequent one (47.9%). Out of 146 individuals, 43 (29.5%) were homozygous for all nine HLA loci, encompassing three distinct haplotypes. In addition, the two (out of 21 different combinations) most frequent HLA‐DPA1~DPB1 haplotypes were HLA‐DPA1*02:01:02:02 ~ DPB1*01:01:01:01 and HLA‐DPA1*01:03:01:02 ~ DPB1*04:01:01:01 which were significantly more prevalent ( P corr < 0.0001 each). Our study provides valuable insights on the polymorphism of nine HLA loci within 8.1 extended haplotype, highlighting 4th‐field allelic variations and potential haplotype formation preferences. Additionally, it underscores the genetic diversity of HLA‐DPA1~DPB1 within 8.1 extended haplotype, which may influence its role in disease associations.
An intermediate‐sized donor registry experience: HLA barriers in matching procedures
The data enabling the estimation of the possibility of finding a matched unrelated donor (MUD) within a relatively short time is important for the success of hematopoietic stem cell transplantation (HSCT). In the present study, 738 unrelated Croatian patients in the program of unrelated HSCT were retrospectively analyzed for gender matching, donor origin (national or international), the distribution of HLA alleles and haplotypes, as well as for the probability of finding a 9‐10/10 MUD. Almost 70% of the patients in our study group had a 10/10 MUD, while among the patients with a 9/10 MUD, a 1st field resolution level mismatched donor was selected for 55.0% of patients. The majority of pairs were HLA‐A mismatched (33.8%). A comparison of HLA allele frequencies between two subgroups of patients revealed significant differences for 13 alleles. However, after p value correction, the difference in frequency remained significant only for four alleles; three HLA alleles (B*08:01, C*07:01, and DRB1*03:01) demonstrated a significantly higher frequency among patients with a 10/10 MUD (Pcorr < 0.0001, Pcorr = 0.0096, and Pcorr < 0.0001, respectively), while the B*35:08 allele was significantly more present among patients with a 9/10 MUD (Pcorr = 0.0328). The comparison of the distribution of HLA haplotypes between patients with a 10/10 MUD and patients with a 9/10 MUD showed significant differences for a number of two‐locus and three‐locus haplotypes, as well as for one five‐locus haplotype (HLA‐A*01:01~B*08:01~C*07:01~DRB1*03:01~DQB1*02:01), which was significantly more present in the group of patients with a 10/10 MUD. At least one HLA haplotype from the group of non‐frequent HLA haplotypes (positions >1000) was carried by patients with a 9/10 MUD. The data obtained by the present study will contribute to a better estimation of the probability of finding a suitable 9‐10/10 MUD for Croatian patients in need of HSCT.
An intermediate‐sized donor registry experience: HLA barriers in matching procedures
The data enabling the estimation of the possibility of finding a matched unrelated donor (MUD) within a relatively short time is important for the success of hematopoietic stem cell transplantation (HSCT). In the present study, 738 unrelated Croatian patients in the program of unrelated HSCT were retrospectively analyzed for gender matching, donor origin (national or international), the distribution of HLA alleles and haplotypes, as well as for the probability of finding a 9‐10/10 MUD. Almost 70% of the patients in our study group had a 10/10 MUD, while among the patients with a 9/10 MUD, a 1st field resolution level mismatched donor was selected for 55.0% of patients. The majority of pairs were HLA‐A mismatched (33.8%). A comparison of HLA allele frequencies between two subgroups of patients revealed significant differences for 13 alleles. However, after p value correction, the difference in frequency remained significant only for four alleles; three HLA alleles (B*08:01, C*07:01, and DRB1*03:01) demonstrated a significantly higher frequency among patients with a 10/10 MUD (Pcorr < 0.0001, Pcorr = 0.0096, and Pcorr < 0.0001, respectively), while the B*35:08 allele was significantly more present among patients with a 9/10 MUD (Pcorr = 0.0328). The comparison of the distribution of HLA haplotypes between patients with a 10/10 MUD and patients with a 9/10 MUD showed significant differences for a number of two‐locus and three‐locus haplotypes, as well as for one five‐locus haplotype (HLA‐A*01:01~B*08:01~C*07:01~DRB1*03:01~DQB1*02:01), which was significantly more present in the group of patients with a 10/10 MUD. At least one HLA haplotype from the group of non‐frequent HLA haplotypes (positions >1000) was carried by patients with a 9/10 MUD. The data obtained by the present study will contribute to a better estimation of the probability of finding a suitable 9‐10/10 MUD for Croatian patients in need of HSCT.
- Open Access
- 7 April 2021
- Published by Wiley in Journal of Immunology Research
- Vol. 2021, 1-12
Mapping the Human Leukocyte Antigen Diversity among Croatian Regions: Implication in Transplantation
In the present study, HLA allele and haplotype frequencies were studied using the HLA data of 9277 Croatian unrelated individuals, typed using high-resolution methods for the HLA-A, -B, -C, and -DRB1 loci. The total numbers of observed alleles were 47 for HLA-A, 88 for HLA-B, 34 for HLA-C, and 53 for HLA-DRB1. HLA-A02:01 (29.5%), B51:01 (10.5%), C04:01 (15.8%), and DRB116:01 (10.4%) were the most frequent alleles in the Croatian general population. The three most frequent haplotypes were HLA-A01:01~C07:01~B08:01~DRB103:01 (4.7%), HLA-A03:01~C07:02~B07:02~DRB115:01 (1.7%), and HLA-A02:01~C07:01~B18:01~DRB111:04 (1.5%). Allele and haplotype frequencies were compared between national and regional data, and differences were observed, particularly in the North Croatia region. The data has potential use in refining donor recruitment strategies for national registries of volunteer hematopoietic stem cell donors, solid organ allocation schemes, and the design of future disease and anthropological studies.
- 7 April 2021
- Published by Wiley in Journal of Immunology Research
- Vol. 2021, 1-12
Open AccessMapping the Human Leukocyte Antigen Diversity among Croatian Regions: Implication in Transplantation
In the present study, HLA allele and haplotype frequencies were studied using the HLA data of 9277 Croatian unrelated individuals, typed using high-resolution methods for the HLA-A, -B, -C, and -DRB1 loci. The total numbers of observed alleles were 47 for HLA-A, 88 for HLA-B, 34 for HLA-C, and 53 for HLA-DRB1. HLA-A02:01 (29.5%), B51:01 (10.5%), C04:01 (15.8%), and DRB116:01 (10.4%) were the most frequent alleles in the Croatian general population. The three most frequent haplotypes were HLA-A01:01~C07:01~B08:01~DRB103:01 (4.7%), HLA-A03:01~C07:02~B07:02~DRB115:01 (1.7%), and HLA-A02:01~C07:01~B18:01~DRB111:04 (1.5%). Allele and haplotype frequencies were compared between national and regional data, and differences were observed, particularly in the North Croatia region. The data has potential use in refining donor recruitment strategies for national registries of volunteer hematopoietic stem cell donors, solid organ allocation schemes, and the design of future disease and anthropological studies.
Detection of novel and confirmation of very rare and rare HLA alleles by next generation sequencing in Croatia
Routine HLA typing in clinical practice encompassing solid organ and hematopoietic stem cells transplantation programs, disease association typing, volunteer marrow donor typing and population studies, provided a large dataset for studying HLA allele polymorphism in the Croatian population which led to the identification of new, very rare and rare HLA alleles. Over the last four years we have identified six new HLA alleles (HLA‐A*01:200, A*02:836, A*11:01:01:44, B*08:251, B*18:169 and C*05:46:01:02) and a number of very rare (HLA‐B*08:78, DRB1*12:39, DRB1*13:23:02 and DQB1*06:09:04) or rare (HLA‐A*24:41, B*39:40:01 N, B*51:78:01, DRB1*01:31 and DRB1*14:111) alleles using sequence‐based typing methods. The reported data enhance the knowledge about HLA polymorphisms in the Croatian population and provide a foundation for further studies in population genetics.
Detection of novel and confirmation of very rare and rare HLA alleles by next generation sequencing in Croatia
Routine HLA typing in clinical practice encompassing solid organ and hematopoietic stem cells transplantation programs, disease association typing, volunteer marrow donor typing and population studies, provided a large dataset for studying HLA allele polymorphism in the Croatian population which led to the identification of new, very rare and rare HLA alleles. Over the last four years we have identified six new HLA alleles (HLA‐A*01:200, A*02:836, A*11:01:01:44, B*08:251, B*18:169 and C*05:46:01:02) and a number of very rare (HLA‐B*08:78, DRB1*12:39, DRB1*13:23:02 and DQB1*06:09:04) or rare (HLA‐A*24:41, B*39:40:01 N, B*51:78:01, DRB1*01:31 and DRB1*14:111) alleles using sequence‐based typing methods. The reported data enhance the knowledge about HLA polymorphisms in the Croatian population and provide a foundation for further studies in population genetics.
- 1 January 2020
- Published by Elsevier in Human Immunology
- Vol. 81 (1) , 12-17
The MHC gamma block matching: Impact on unrelated hematopoietic stem cell transplantation outcome
- 1 January 2020
- Published by Elsevier in Human Immunology
- Vol. 81 (1) , 12-17
The MHC gamma block matching: Impact on unrelated hematopoietic stem cell transplantation outcome
Association of HLA alleles and haplotypes with CYP21A2 gene p. V282L mutation in the Croatian population
The CYP21A2 mutations that are in linkage disequilibrium with particular HLA‐A, ‐B, ‐DRB1 alleles/haplotypes, cause deficiency of the 21‐hydroxylase enzyme (21‐OHD) and account for the majority of congenital adrenal hyperplasia (CAH) cases. The aim of this study was to investigate those associations with the p.V282L mutation linked to the non‐classical (NC) form of CAH among Croatians. The study included parents of patients with the NC form of CAH, positive for the p.V282L mutation (N = 55) and cadaveric donor samples (N = 231). All subjects were HLA‐A, ‐B, and ‐DRB1 typed and tested for the presence of the p.V282L mutation. Among parents of patients, 92.73% of subjects were positive for the B*14:02 allele and almost half of them carried the HLA‐A*33:01‐B*14:02‐DRB1*01:02 haplotype. Among cadaveric samples 77 out of 96 subjects positive for the B*14:02 allele had the p.V282L mutation. Among them, 37 were positive for the HLA‐A*33:01‐B*14:02‐DRB1*01:02 haplotype, 23 had the HLA‐A*33:01‐B*14:02‐DRB1*03:01 haplotype, 8 had the B*14:02‐DRB1*01:02 combination and 5 were carrying the HLA‐A*68:02‐B*14:02‐DRB1*13:03 haplotype. Only 4 of these subjects were positive for the B*14:02 allele. HLA‐B*14:02 was the only single allele with association that reached statistically significant P value (RR = 12.00; P = 0.0024). Haplotypes B*14:02‐DRB1*01:02 (P < 0.001) and HLA‐A*68:02‐B*14:02‐DRB1*13:03 (P < 0.001) as well as HLA‐A*33:01‐B*14:02‐DRB1*01:02 and HLA‐A*33:01‐B*14:02‐DRB1*03:01 showed high relative risks (RR = 45.00, RR = 41.63 and RR = 36.96, respectively). Our data support the previously documented association of the HLA‐A*33:01‐B*14:02‐DRB1*01:02 haplotype with the p.V282L mutation, but also point out a high frequency of the p.V282L mutation among Croatians with HLA‐A*33:01‐B*14:02‐DRB1*03:01 and HLA‐A*68:02‐B*14:02‐DRB1*13:03 haplotypes.
Association of HLA alleles and haplotypes with CYP21A2 gene p. V282L mutation in the Croatian population
The CYP21A2 mutations that are in linkage disequilibrium with particular HLA‐A, ‐B, ‐DRB1 alleles/haplotypes, cause deficiency of the 21‐hydroxylase enzyme (21‐OHD) and account for the majority of congenital adrenal hyperplasia (CAH) cases. The aim of this study was to investigate those associations with the p.V282L mutation linked to the non‐classical (NC) form of CAH among Croatians. The study included parents of patients with the NC form of CAH, positive for the p.V282L mutation (N = 55) and cadaveric donor samples (N = 231). All subjects were HLA‐A, ‐B, and ‐DRB1 typed and tested for the presence of the p.V282L mutation. Among parents of patients, 92.73% of subjects were positive for the B*14:02 allele and almost half of them carried the HLA‐A*33:01‐B*14:02‐DRB1*01:02 haplotype. Among cadaveric samples 77 out of 96 subjects positive for the B*14:02 allele had the p.V282L mutation. Among them, 37 were positive for the HLA‐A*33:01‐B*14:02‐DRB1*01:02 haplotype, 23 had the HLA‐A*33:01‐B*14:02‐DRB1*03:01 haplotype, 8 had the B*14:02‐DRB1*01:02 combination and 5 were carrying the HLA‐A*68:02‐B*14:02‐DRB1*13:03 haplotype. Only 4 of these subjects were positive for the B*14:02 allele. HLA‐B*14:02 was the only single allele with association that reached statistically significant P value (RR = 12.00; P = 0.0024). Haplotypes B*14:02‐DRB1*01:02 (P < 0.001) and HLA‐A*68:02‐B*14:02‐DRB1*13:03 (P < 0.001) as well as HLA‐A*33:01‐B*14:02‐DRB1*01:02 and HLA‐A*33:01‐B*14:02‐DRB1*03:01 showed high relative risks (RR = 45.00, RR = 41.63 and RR = 36.96, respectively). Our data support the previously documented association of the HLA‐A*33:01‐B*14:02‐DRB1*01:02 haplotype with the p.V282L mutation, but also point out a high frequency of the p.V282L mutation among Croatians with HLA‐A*33:01‐B*14:02‐DRB1*03:01 and HLA‐A*68:02‐B*14:02‐DRB1*13:03 haplotypes.
Identification of the novel HLA‐A*01:200 allele by sequence‐based typing in a Croatian individual
The new allele HLA-A*01:200 differs from A*01:12 by four nucleotide substitutions in exon 3.
Identification of the novel HLA‐A*01:200 allele by sequence‐based typing in a Croatian individual
The new allele HLA-A*01:200 differs from A*01:12 by four nucleotide substitutions in exon 3.